WHO ICTRP trial
Neonatal Interventional Nebulized Surfactant for Preterm Infants with RDS…
PACTR202307490670785 · Pan African Clinical Trials Registry (PACTR) · Recruiting
Key facts
| Trial ID | PACTR202307490670785 |
|---|---|
| Public title | Neonatal Interventional Nebulized Surfactant for Preterm Infants with RDS (Neo-INSPIRe) |
| Scientific title | A South African, multicenter, phase 2, non-blinded, randomized controlled trial to determine if aerosolized surfactant plus continuous positive airway pressure (CPAP) compared to CPAP alone can improve the course of infants with respiratory distress syndrome (RDS) by decreasing their need for… |
| Primary sponsor | Aerogen Pharma |
| Registry | Pan African Clinical Trials Registry (PACTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase-2 |
| Countries | South Africa;South Africa;South Africa |
| Conditions | Respiratory Paediatrics |
| Registration date | Jul 14, 2023 |
| Target size | 232 |
| Secondary IDs | 270320;APCAFCLN004 |
| Registry page | pactr.samrc.ac.za |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: